Abstract: A package structure includes a semiconductor device and an adhesive pattern. The adhesive pattern surrounds the semiconductor device, wherein an angle ? is formed between a sidewall of the semiconductor device and a sidewall of the adhesive pattern, 0°<?<90° wherein the adhesive layer has a first opening misaligned with a corner of the semiconductor device closest to the first opening.

Abstract: The present invention provides for a method of preparing a nutraceutical formulation comprising the step of solvent extraction from the root of Zingiber zerumbet Sm, and the use of this formulation to regulate the immune system, and more specifically to prevent or to treat an allergic disorder.

Abstract: The present invention provides for a method of preparing a nutraceutical formulation comprising the step of solvent extraction from the root of Zingiber zerumbet Sm, and the use of this formulation to regulate the immune system, and more specifically to prevent or to treat an allergic disorder.

Abstract: A nutraceutical composition containing 0.01-99% by weight polysaccharides enriched from an extract of beans of Glycine max (L.) Merr. Also disclosed are a method of enriching polysaccharides from pulverized beans of Glycine max (L.) Merr.; a polysaccharide having a backbone of ?-(1,6)-linked glucose residues, and one or more galactose or mannose residues are bonded to the C-3 or C-4 position of one or more of the glucose residues by a (1,3)- or a (1,4)-linkage; and a method of treating a subject with such polysaccharides to increase blood cell counts.

Abstract: A nutraceutical composition containing 0.01-99% by weight polysaccharides enriched from an extract of beans of Glycine max (L.) Merr. Also disclosed are a method of enriching polysaccharides from pulverized beans of Glycine max (L.) Merr.; a polysaccharide having a backbone of ?-(1,6)-linked glucose residues, and one or more galactose or mannose residues are bonded to the C-3 or C-4 position of one or more of the glucose residues by a (1,3)- or a (1,4)-linkage; and a method of treating a subject with such polysaccharides to increase blood cell counts.

Abstract: This invention features a method for treating inflammatory injury to the cardiovascular system caused by oxidized low density lipoprotein. The method includes administering to a subject in need an effective amount of a composition containing salvianolic acid B.

Abstract: A nutraceutical composition containing 0.01-99% by weight polysaccharides enriched from an extract of beans of Glycine max (L.) Merr. Also disclosed are a method of enriching polysaccharides from pulverized beans of Glycine max (L.) Merr.; a polysaccharide having a backbone of &agr;-(1,6)-linked glucose residues, and one or more galactose or mannose residues are bonded to the C-3 or C-4 position of one or more of the glucose residues by a (1,3)- or a (1,4)-linkage; and a method of treating a subject with such polysaccharides to increase blood cell counts.

Abstract: The present invention relates to a nutraceutical composition that contains lithospermic acid enriched from an extract of T. samentosa, or contains lithospermic acid and salvianolic acid B co-enriched from an extract of S. miltiorrhiza.

Abstract: The DNA sequence encoding T4 DNA polymerase (gene 43 of T4 phase) has been successfully cloned, thereby providing a convenient source of this enzyme. The method involves the production of a gene 43 NH.sub.2 -terminus fragment absent its promoter. The latter is ligated to a fragment containing the remaining COOH-terminus sequence but lacking base pairs beyond this terminus which heretofore caused destabilization effects in cloning. The full sequence of the DNA sequence has been elucidated. Corresponding cloning methods are disclosed.